Effects of H1- and H2-antihistamines on platelet-activating factor and bradykinin-induced inflammatory responses in human skin

Clinical and Experimental Dermatology

Volumn 21, Issue 1, 1996, Pages 33-37

  Sansom, J E ^a   Brooks, J ^a   Burton, J L ^a   Archer, C B ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ; CIMETIDINE; DOXEPIN; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; TERFENADINE; THROMBOCYTE ACTIVATING FACTOR; CODEINE; HISTAMINE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; HISTAMINE RELEASE; HUMAN; HUMAN EXPERIMENT; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SKIN INFLAMMATION; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DRUG EFFECT; PATHOLOGY; SKIN; URTICARIA;

ADMINISTRATION, ORAL; BRADYKININ; CIMETIDINE; CODEINE; DOUBLE-BLIND METHOD; DOXEPIN; HISTAMINE; HISTAMINE H1 ANTAGONISTS; HISTAMINE H2 ANTAGONISTS; HUMANS; PLATELET ACTIVATING FACTOR; SKIN; TERFENADINE; URTICARIA;

EID: 0029666395     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2230.1996.tb00008.x     Document Type: Article

References (15)

1. Betz SJ, Lotner GZ, Henson PM. Generation and release of platelet-activating factor (PAF) from enriched preparations of rabbit basophils; failure of human basophils to release PAF. J Immunol 1980; 125: 2749-55.
2. Pincknard RN, McManus LM, Hanahan DJ. Chemistry and biology ot acetyl glyceryl ether phosphocholine (platelet-activating factor). In: Weisman G, ed. Advances in Inflammation Research. Raven Press, New York, 1990: 147-80.
3. Zimmerman GA, Whatley RE, McIntyre TM, Prescott SM. Production of platelet-activating factor, a biologically active lipid, by vascular endothelium. Am Rev Respir Dis 1987; 136: 204-7.
4. 1-receptor antagonism on the inflammatory responses to PAF-acether and histamine. Br J Clin Pharmacol 1987; 24: 247P (Abstr.).
5. Sciberras DG, Jordan S, Gill D et al. The role of histamine in the acute inflammatory responses to intradermal platelet-activating factor. Br J Clin Pharmacol 1991; 32: 85-90.
6. 1-antagonists on PAF-acether-induced inflammatory responses in the skin of experimental animals and man. Br J Pharmacol 1985; 85: 109-13.
7. Fjellner B, Hagermark O. Experimental pruritus evoked by platelet-activating factor (PAF-acether) in human skin. Acta Derm Venereol (Stockh) 1985; 65: 409-12.
8. Greaves M, Shuster S. Responses of skin blood vessels to bradykinin, histamine and 5-hydroxytryptamine. J Physiol 1967; 193: 255-67.
9. Crossman DC, Fuller RW. Bradykinin-induced weal and flare is not mediated by histamine release or cyclo-oxygenase products. Br J Clin Pharmacol 1988; 26: 113-15.
10. Li-Kam-Wa TC, Cooke ED, Turner P. Effects of selective histamine receptor antagonists on skin responses to intradermal bradykinin in healthy volunteers. J Pharm Pharmacol 1992; 44: 869-72.
11. Grandel KE, Farr RS, Wanderer AA et al. Association of platelet-activating factor with primary acquired cold urticaria. N Engl J Med 1985; 313: 405-9.
12. Wallengren J, Hakanson R. Effects of capsaicin, bradykinin and prostaglandin E, in the human skin. Br J Dermatol 1992; 126: 111-17.
13. Crimi N, Polosa R, Maccarone C et al. Effect of topical application with capsaicin on skin responses to bradykinin and histamine in man. Clin Exp Allergy 1992; 22: 933-9.
14. Greaves M, Marks R, Robertson I. Receptors for histamine in human skin blood vessels: a review. Br J Dermatol 1977; 97: 225-8.
15. Archer CB. Platelet activating factor - a mediator of inflammation in the skin - medical implications. Clin Exp Dermatol 1993; 18: 489-95.